Dysbiosis: Clinical Trials

177 trials for Dysbiosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

81 completed, 30 recruiting, 22 unknown, 15 active not recruiting. 93 Not applicable, 13 Phase 2, 11 Phase 4, 10 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable93Completed 42, Recruiting 17, Unknown 12, Active not recruiting 9, Not yet recruiting 9, Enrolling by invitation 2, Terminated 1, Withdrawn 1
Phase 213Recruiting 3, Terminated 3, Active not recruiting 2, Completed 2, Enrolling by invitation 1, Unknown 1, Withdrawn 1
Phase 411Completed 5, Not yet recruiting 3, Enrolling by invitation 2, Unknown 1
Phase 110Completed 5, Terminated 2, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Phase 33Unknown 2, Terminated 1
Early Phase 12Completed 1, Unknown 1

Follow Dysbiosis: new trials by email Literature Review of Dysbiosis trials Research Report on Dysbiosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders
Fecal Microbiota Transplant - Autism, Autism Spectrum Disorder
Phase 1Not yet recruitingProgenaBiome102027-05-012026-09-18
Microbiota Changes Related to Outcomes in Kidney Transplantation
Fecal samples, Urinary sample, Blood samples - End-stage Renal Disease (ESRD), Kidney Transplantation
Not yet recruitingHospices Civils de Lyon302027-01-012026-10-26
Herbal Supplement (Biocidin REMOVE) for Bacterial Overgrowth in Irritable Bowel Syndrome
Biocidin REMOVE, Placebo - Irritable Bowel Syndrome (IBS), Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
Phase 2Enrolling by invitationJohns Hopkins University402026-10-262026-11-03
Almonds, Gut Microbiome and Kids
Creamy Richards 100% Almonds! Creamy Natural Almond Butter, Cadbury Milk Chocolate Spread - Dysbiosis, Cardiometabolic Health Indicators
Not applicableRecruitingFlorida State University702026-10-242026-11-09
FMT for 90-Day Outcome of Clinical Use in ICU Sepsis
Gut microbiota suspension - Sepsis, Critical Illness
Not applicableNot yet recruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology602026-10-152026-09-24
Pulse Education and Children
Education Only, Education + Pulse Provision, Cooking Class - Dysbiosis, Cardiometabolic Health Indicators
Not applicableRecruitingFlorida State University602026-10-152026-11-09
Effects of Synbiotic Supplementation on Gastrointestinal Symptoms, Appetite, and Nutritional Recovery in Patients After Autologous Bone Marrow Transplant
Tri-component Synbiotic Supplement - Hematologic Neoplasms, Gastrointestinal Symptoms
Not applicableNot yet recruitingAlexandria University402026-10-012026-10-01
Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV
Vaginal estradiol tablets, Vaginal moisturizer - Menopausal Complaints, Vaginal Atrophy
Phase 4Not yet recruitingAlbert Einstein College of Medicine622026-09-012026-07-28
Effect of a Probiotic or Postbiotic on Gut Microbiome During Antibiotic Treatment
Probiotic, Postbiotic, Placebo - Microbiome
Not applicableRecruitingThe Archer-Daniels-Midland Company1262026-08-272026-10-28
Dietary Pattern Intervention for Neurodevelopment in Preterm Infants
Structured High-Prebiotic Dietary Pattern - Preterm, Neurodevelopmental Disorders
Not applicableNot yet recruitingFudan University1162026-07-012026-07-14
Metabolic and Functional Study of γδ T Cells in Critically Ill Patients
Sepsis, Critical Illness
RecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology1052026-06-212026-10-27
Cachexia and Gut Microbiota in Patients With Breast Cancer Receiving Home Care
Probiotic Mixture, Placebo - Breast Cancer, Cancer Cachexia
Not applicableNot yet recruitingFondazione ANT Franco Pannuti ETS1402026-06-012026-06-17
Probiotics Supplementation for Neurodevelopment in Preterm Infants
Probiotic Mixture (Bifidobacterium animalis subsp. lactis Bb-12 and Lacticaseibacillus rhamnosus LGG) - Premature Birth, Neurodevelopmental Disorders
Not applicableNot yet recruitingFudan University1162026-06-012026-06-01
Algal Lutein Against Decline of Intellectual Nimbleness
Lutein, Placebo - Menopausal Syndrome, Cognitive Decline
Not applicableNot yet recruitingPoznan University of Life Sciences3002026-05-012026-05-20
From Commensalism to Pathogenicity: Exploring the Pathophysiology of Bacteremia to Better Understand Enterococcus Faecalis Infective Endocarditis
Microbiological sampling (swab collection) - Infective Endocarditis (IE)
Not applicableRecruitingUniversity Hospital, Clermont-Ferrand902026-04-172026-10-13
Impact of Internal Menstrual Protections on Immunity and Vaginal Microbiota
Samples collection (whole blood, urine, vaginal and cervical cells) - Sexual Transmitted Disease, Vaginosis, Bacterial
RecruitingCentre National de la Recherche Scientifique, France3002026-04-072026-04-09
Effects Of Periodontal Therapy In Patients With Inflammatory Bowel Disease
Periodontal Diseases, IBD
RecruitingUniversity of Turin, Italy302026-03-032026-10-30
PremaBiom: Metatranscriptomics of the Respiratory Microbiome to Predict the Occurrence of Bronchopulmonary Dysplasia in Preterm Infants
Nasal swab, blood sampling, Mother milk sampling - Bronchopulmonary Dysplasia, Preterm Infant Development
Not applicableNot yet recruitingUniversity Hospital, Caen2702026-03-012026-02-13
Evaluation Through Innovative Examinations of Intestinal Dysbiosis Status in Patients Diagnosed With Cardiovascular Diseases and Evaluation of the Efficacy of Natural and Probiotic Extracts in the Non-pharmacological Approach to Improving Intestinal Dysbiosis Status.
Tea tree (Melaleuca alternifolia), Cinnamon (Cynnamomum zeylanicum) bark, Clove carnation (Eugenia caryopyllus) flowers, Red thyme (Thymus vulgaris) plant - Acute Coronary Syndromes (ACS)
Not applicableRecruitingCasa di Cura Dott. Pederzoli152026-03-012026-02-24
Limosilactobacillus Fermentum CRL 1446 - CONICET CASASCO
Limosilactobacillus fermentum 1446 CRL CONICET 2.20E+9 CFU, Placebo (inert excipient) - Disbiosis, Obesity
Not applicableActive not recruitingPINER Pastor Manfredi Winery802026-02-022026-05-14

Showing 20 of 177. Sign in to see all of them.

Narrower conditions

Inflammation (23)  ·  Obesity (14)  ·  Irritable Bowel Syndrome (10)  ·  Periodontal Diseases (6)  ·  Periodontitis (6)  ·  HIV Infections (5)  ·  Inflammatory Bowel Diseases (5)  ·  Overweight (5)  ·  Communicable Diseases (4)  ·  Critical Illness (4)  ·  Crohn Disease (4)  ·  Premature Birth (4)  ·  Axial Spondyloarthritis (3)  ·  COVID-19 (3)

Broader conditions

Pathologic Processes (177)  ·  Pathological Conditions, Signs and Symptoms (177)  ·  Digestive System Diseases (41)  ·  Infections (36)  ·  Gastrointestinal Diseases (33)  ·  Signs and Symptoms (32)  ·  Intestinal Diseases (28)  ·  Nutritional and Metabolic Diseases (28)  ·  Disease Attributes (22)  ·  Urogenital Diseases (20)  ·  Nutrition Disorders (19)  ·  Colonic Diseases (17)  ·  Body Weight (15)  ·  Overnutrition (15)  ·  Female Urogenital Diseases and Pregnancy Complications (14)

Interventions

Fecal Microbiota Transplantation (8)  ·  Probiotics (7)  ·  Blood Specimen Collection (5)  ·  Anti-Bacterial Agents (3)  ·  Standard of Care (3)  ·  Ciprofloxacin (2)  ·  Defecation (2)  ·  Estradiol (2)  ·  Inulin (2)  ·  Lacteol (2)  ·  Methods (2)  ·  Metronidazole (2)  ·  Prebiotics (2)  ·  Rifaximin (2)  ·  Root Planing (2)

Sponsors

Florida State University (5)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  Universitaire Ziekenhuizen KU Leuven (3)  ·  University of Turin, Italy (3)  ·  Azienda di Servizi alla Persona di Pavia (2)  ·  Boston Medical Center (2)  ·  Emory University (2)  ·  Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (2)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2)  ·  Fudan University (2)  ·  Haukeland University Hospital (2)  ·  Igenomix (2)  ·  Industrial Microbiology LLP (2)  ·  Mebo Research, Inc. (2)

Countries

United States (43)  ·  Italy (21)  ·  France (18)  ·  Spain (13)  ·  Canada (7)  ·  China (6)  ·  Poland (5)  ·  Taiwan (5)  ·  Turkey (Türkiye) (5)  ·  Norway (4)  ·  South Korea (4)  ·  Belgium (3)  ·  Brazil (3)  ·  United Kingdom (3)  ·  Argentina (2)

Top investigators

Ravinder Nagpal, PhD (3)  ·  Corinne Gower-Rousseau, MD, PhD (2)  ·  Ilyas Kulmagambetov, Doctor of Med. Sc. (2)  ·  Irene Gabashvili, PhD (2)  ·  Kerry J Murphy, MD (2)  ·  Luis Garcia-Ortiz (2)  ·  Ravinder Nagpal, Ph.D. (2)  ·  Tim Vanuytsel, MD PhD (2)  ·  Agnieszka Owczarczyk-Saczonek, Prof (1)  ·  Aida Lydia, MD, PhD (1)  ·  Andre Marette (1)  ·  Ayesha Abdeen, MD (1)  ·  Basilio Malamisura (1)  ·  Benjamin Shayo, MD (1)

Results publications

PMID 10807119, PMID 16280441, PMID 18972769, PMID 19143664, PMID 19343057, PMID 19789064, PMID 21480966, PMID 22265264, PMID 22572877, PMID 22829885, PMID 23252527, PMID 23489056, PMID 24891990, PMID 25612669, PMID 25644890, PMID 26000024, PMID 26542800, PMID 26941724, PMID 27787759, PMID 28390459, PMID 28524627, PMID 28605006, PMID 29100842, PMID 29615661, PMID 29723083, PMID 29882884, PMID 30157383, PMID 30315206, PMID 30480772, PMID 30897686, PMID 30937345, PMID 31111407, PMID 31231311, PMID 31270648, PMID 32173258, PMID 32258202, PMID 32385871, PMID 32433595, PMID 32484877, PMID 32600259, PMID 32633595, PMID 33211762, PMID 33303304, PMID 33346007, PMID 33394167, PMID 33574140, PMID 33784312, PMID 33964852, PMID 34105575, PMID 34358486

NIH funding

2019 (1), 2023 (1), D43TW012274 (1), K23AG062400 (1), K23AI163351 (1), R01AA030485 (1), R01AG102277 (1)